Your session is about to expire
← Back to Search
NT-proBNP Screening for Heart Failure (SYMPHONY-HF Trial)
SYMPHONY-HF Trial Summary
This trial studies a better way to screen for hidden heart failure in people at high risk.
SYMPHONY-HF Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSYMPHONY-HF Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.SYMPHONY-HF Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am able to understand and agree to the study's procedures and risks.I have had surgery or a procedure for blocked arteries in my legs.I have had a heart attack or surgery/intervention for blocked heart arteries.I have been diagnosed with COPD.I have chronic kidney disease with specific kidney function levels.I have had a stroke caused by a clot.My heart condition is persistent or permanent atrial fibrillation.I have been diagnosed with diabetes.You have two or more factors that increase the risk of heart failure.I have been taking water pills regularly for over a month.I am on dialysis.I have been diagnosed with heart failure before.I am 40 years old or older.
- Group 1: Routine care arm
- Group 2: Investigational arm
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What is the cap for participants in this experiment?
"The sponsor, AstraZeneca, will need to recruit 3904 participants that meet the inclusion criteria for this trial. These patients can be found at two locations in Canada: University of British Columbia in Vancouver and University of Montreal in Montréal."
Is this trial currently open for enrolment?
"Affirmative, the trial is actively seeking participants. According to clinicaltrials.gov, this study was first presented on December 22nd 2022 and has been recently revised on June 22nd 2023. In total, 3904 volunteers are needed at 7 distinct medical hubs."
How many facilities are currently running this research program?
"Currently, this trial is being conducted at 7 different locations around the world. These include Vancouver, Montréal and Copenhagen as well as 4 other cities. To minimize travel demands enrolled patients should select a site nearest to them."
Share this study with friends
Copy Link
Messenger